Home
About
Overview
Sharing Data
ORCID
Help
History (16)
Beaser, Andrew
Preferences for in-person disclosure: Patients declining telephone disclosure characteristics and outcomes in the multicenter Communication Of GENetic Test Results by Telephone study.
Fathers and the well-child visit.
Examining emotion-, personality-, and reward-related dispositional tendencies in relation to eating pathology and weight change over seven years in the Longitudinal Assessment of Bariatric Surgery (LABS) study.
ß1 integrin monoclonal antibody treatment ameliorates cerebral cavernous malformations.
See All 16 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
ß1 integrin monoclonal antibody treatment ameliorates cerebral cavernous malformations.
ß1 integrin monoclonal antibody treatment ameliorates cerebral cavernous malformations. FASEB J. 2022 12; 36(12):e22629.
View in:
PubMed
subject areas
Animals
Antibodies, Monoclonal
Hemangioma, Cavernous, Central Nervous System
Human Umbilical Vein Endothelial Cells
Humans
Integrin beta1
Integrins
Mice
Microtubule-Associated Proteins
authors with profiles
Issam Awad
Robert Shenkar